Search for Clinical Trial Results
Extranodal Nasal NK/T Cell Lymphoma - 24 Studies Found
Status | Study |
Completed |
Study Name: Gemcitabine in NK/T Cell Lymphoma Condition: NK/T Cell Lymphoma Date: 2012-08-06 |
Completed |
Study Name: Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma Condition: Extranodal NK/T-cell Lymphoma, Nasal Type Date: 2012-08-13 Interventions: Drug: Radiotherapy followed by chemotherapy Radiotherapy Technique: IMRT Total dose: 50 Gy Per fraction: |
Recruiting |
Study Name: Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma Condition: Extranodal NK/T-cell Lymphoma, Nasal Type Date: 2013-08-03 Interventions:
|
Active, not recruiting |
Study Name: GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma Condition: Extranodal NK/T-cell Lymphoma, Nasal Type Date: 2013-11-07 Interventions:
|
Terminated |
Study Name: Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma Condition: Extranodal NK/T-cell Lymphoma, Nasal Type Date: 2012-08-13 Interventions:
|
Completed |
Study Name: Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma Condition: Extranodal NK/T Cell Lymphoma Date: 2011-04-21 |
Completed |
Study Name: International Extranodal NK/T-cell Lymphoma Project Condition: Extranodal NK/T-cell Lymphoma, Nasal Type Date: 2015-03-06 |
Active, not recruiting |
Study Name: Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma Condition: Nasal Type Extranodal NK/T-Cell Lymphoma Date: 2015-11-22 Interventions:
|
Active, not recruiting |
Study Name: Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma Condition: Stage I/II Extranodal NK/T-cell Lymphoma Date: 2009-11-02 Interventions: Other: concomitant chemo-radiotherapy followed by VIDL chemotherapy with risk-based application of autologous stem cell transplantation |
Not yet recruiting |
Study Name: Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy Condition:
|